CLINICAL_TRIALS
trial_result
· 2023-04-24
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight [Phase 3]
Summary
This clinical trial update reports Phase 3 results for tirzepatide in adults with obesity or overweight, with results posted on 2023-04-24.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2023-04-24